The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1263 articles
Popular GLP-1 drugs like Ozempic and Wegovy are curbing appetites, prompting restaurants to adapt with specialized menus. Cuba Libre's Barry Gutin explains their high-protein, smaller-portion offerings designed with a doctor's input. This trend signals a lasting change in dining habits.
GLP-1 medications like Ozempic and Wegovy have surged in popularity for weight loss and Type II diabetes management, but celebrities are now sharing alarming side effects. Bunnie Xo revealed suicidal ideations after using one, while her husband Jelly Roll shed nearly 300 pounds naturally. This guide examines the risks and promotes healthier paths.
Telehealth giant Hims & Hers stirred controversy by launching a cheap compounded version of Novo Nordisk's Wegovy pill, only to yank it days later amid FDA crackdowns and lawsuits. This incident highlights the ongoing Wild West in the knockoff GLP-1 market, where unapproved compounded drugs flood the scene despite resolved shortages. Patients risk ineffective or unsafe products—here's what you need to know.
Novo Nordisk's lawsuit against Hims & Hers claims compounded semaglutide sales are illegal now that shortages ended. But is this about patient safety or enforcing high prices like $150/month for Wegovy pills versus $50 alternatives? Dive into how patents create artificial semaglutide shortages.
McDonald's executives revealed plans to cater to the growing number of customers on GLP-1 drugs like Ozempic during their latest earnings call. With users seeking high-protein options and avoiding sugary drinks, the chain is testing menu tweaks. This shift reflects broader changes in the food industry as GLP-1 adoption hits 10% of the US population.
A nasal spray version of semaglutide, the active ingredient in Ozempic and Wegovy, could soon offer an affordable alternative for weight loss. Chinese firm Shanghai Shiling Pharmaceutical is advancing trials, aiming for global markets by 2028 amid soaring demand. This development aligns with Novo Nordisk's upcoming patent loss in China, paving the way for cheaper generics.
Comedian and influencer Aishwarya Mohanraj bravely shared that weekly Mounjaro injections helped her shed 22kg in just 6 months, from 74kg to 52kg, overcoming deep insecurities. Soha Ali Khan commended her candor, saying 'so finally someone said it' in an industry rife with simplified transformation tales. Learn the details and what Mounjaro means for weight loss.
In a refreshing moment of candor amid the Ozempic debate, Bollywood actress Soha Ali Khan has praised influencer Aishwarya Mohanraj for admitting her use of Mounjaro for weight loss. This celebrity endorsement underscores growing openness about GLP-1 medications in entertainment circles. Discover the science behind these drugs and their implications for metabolic health.
Telehealth firm Hims & Hers sparked chaos by launching a cheap compounded Wegovy pill, only to yank it days later amid FDA crackdowns and a Novo Nordisk lawsuit. This incident highlights the ongoing Wild West in the knockoff GLP-1 market. Despite resolved shortages for Wegovy and Zepbound, unregulated compounded drugs remain widely available.
